FDA Inspection 1237751 — SGF North Carolina PLLC
The FDA completed an inspection of SGF North Carolina PLLC on Apr 30, 2024 in Cary, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cary, NC (United States)